Carmignac Gestion Cuts Stock Holdings in Colgate-Palmolive Company $CL

Carmignac Gestion cut its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 79.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 236,202 shares of the company's stock after selling 917,189 shares during the period. Carmignac Gestion's holdings in Colgate-Palmolive were worth $20,156,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in CL. Teacher Retirement System of Texas increased its position in Colgate-Palmolive by 35.3% during the 4th quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company's stock worth $37,110,000 after purchasing an additional 122,634 shares in the last quarter. Flputnam Investment Management Co. lifted its position in Colgate-Palmolive by 7.4% during the fourth quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company's stock valued at $15,881,000 after buying an additional 13,804 shares in the last quarter. SEB Asset Management AB purchased a new stake in Colgate-Palmolive during the first quarter worth approximately $91,149,000. Caprock Group LLC increased its position in shares of Colgate-Palmolive by 116.5% in the fourth quarter. Caprock Group LLC now owns 64,808 shares of the company's stock worth $5,121,000 after acquiring an additional 34,879 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of Colgate-Palmolive by 10.5% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 221,443 shares of the company's stock worth $17,498,000 after acquiring an additional 21,109 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on CL shares. UBS Group lifted their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company a "buy" rating in a report on Thursday, July 16th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $99.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Barclays upped their target price on Colgate-Palmolive from $80.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Finally, JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $96.00 to $104.00 and gave the company an "overweight" rating in a research note on Thursday, July 16th. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $97.82.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $91.29 on Monday. The company has a debt-to-equity ratio of 16.33, a current ratio of 0.45 and a quick ratio of 0.30. The company's fifty day moving average price is $90.97 and its two-hundred day moving average price is $89.49. The firm has a market capitalization of $73.05 billion, a P/E ratio of 36.23, a P/E/G ratio of 4.80 and a beta of 0.33. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The company had revenue of $5.36 billion during the quarter, compared to the consensus estimate of $5.36 billion. During the same period last year, the firm earned $0.92 earnings per share. The company's revenue was up 4.9% on a year-over-year basis. On average, research analysts anticipate that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive's dividend payout ratio (DPR) is 82.49%.

Colgate-Palmolive News Summary

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Second-quarter adjusted/base-business EPS was $0.99, exceeding the $0.95 consensus estimate and rising from $0.92 a year earlier. Revenue increased 4.9% year over year to $5.36 billion, in line with expectations. Colgate-Palmolive Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability improved, with GAAP and base-business gross margins expanding 140 basis points to 61.5%. Productivity gains and organic sales growth helped offset increased brand investment, while Latin America led regional growth and toothpaste maintained its global leadership. Colgate Q2 Earnings Beat Estimates on Strong Margins
• Neutral Sentiment: Management reaffirmed its full-year sales forecast, with expected revenue of approximately $20.8 billion to $21.6 billion. Maintaining guidance supports stability, but the range signals limited visibility in a choppy consumer environment. Colgate-Palmolive Reaffirms Annual Sales Forecast
• Negative Sentiment: North American demand remained muted, creating concern that the company’s strongest international performance may not fully offset weakness in its largest developed market. Investors also focused on management’s warning that new tariffs could outweigh a recent refund benefit, potentially pressuring future earnings. Colgate Warns New Tariffs Will Outweigh Recent Refund Windfall
• Negative Sentiment: GAAP EPS declined 5% to $0.86 despite the adjusted earnings beat, and organic sales growth was only 2.4%. The combination of slower underlying growth, domestic weakness and tariff risk is outweighing the quarter’s positive margin and earnings performance.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.